Participating Faculty: Improving Transitions of Care for Patients With Thromboembolic Disease

This supplement to The American Journal of Managed Care summarizes proceedings from a roundtable meeting that was conducted to identify quality gaps around transitions of care and explore ways to improve transitions of care, particularly for patients with or at risk for thromboembolic disease.

Please see page S80 in this publication for faculty disclosure information.

This publication was prepared by James Borwick and Kara Guarini, MS, on behalf of The American Journal of Managed Care.

Janssen Pharmaceuticals, Inc

This publication was developed by the staff of The American Journal of Managed Care, with editorial and financial support provided by .

Participating faculty received an honorarium for their attendance at the roundtable meeting and for providing their perspectives.

Faculty

Gary M. Owens, MD—Moderator

President

Gary Owens Associates

Ocean View, Delaware

Claudia Fine, MSW, MPH

Chief of Professional Services

Humana Cares/SeniorBridge

Humana

New York, New York

Darrell W. Harrington, MD

Associate Medical Director, Education

Chief, Division of General Internal Medicine

Harbor-UCLA Medical Center

Torrance, California

Professor of Medicine

David Geffen School of Medicine,

Los Angeles, California

Alan K. Jacobson, MD, FACC

Director of Anticoagulation Services

Cardiology Section

VA Loma Linda HealthCare System

Loma Linda, California

Assistant Professor

Department of Internal Medicine

Loma Linda University School of Medicine

Loma Linda, California

Geno J. Merli, MD

Professor of Medicine and Surgery

Jefferson Medical College

Thomas Jefferson University

Philadelphia, Pennsylvania

Co-Director

Jefferson Vascular Center

Chief Medical Officer and Senior Vice President

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania

Edith Nutescu, PharmD, FCCP

Clinical Professor

Department of Pharmacy Practice

Department of Pharmacy Systems, Outcomes and Policy

Co-Director, Center for Pharmacoepidemiology & Pharmacoeconomic Research

College of Pharmacy

University of Illinois

Chicago, Illinois

Clinical Director, Antithrombosis Clinic

Co-Director, Pharmacogenomics Service

University of Illinois Hospital & Health Sciences System

Chicago, Illinois

Kenneth L. Schaecher, MD, FACP, CPC

Medical Director

SelectHealth

Salt Lake City, Utah

Jacqueline Vance, RNC, BSN, CDONA/LTC, FACDONA

Director

Clinical Affairs

AMDA — Dedicated to Long Term Care Medicine

Columbia, Maryland

Tomas Villanueva, DO, MBA, FACPE, SFHM

Assistant Vice President

Medical Director

Baptist Health Medical Group

Coral Gables, Florida

Albert L. Waldo, MD

The Walter H. Pritchard Professor of Cardiology

Professor of Medicine

Professor of Biomedical Engineering

Case Western Reserve University

Cleveland, Ohio

Harrington Heart and Vascular Institute

University Hospitals Case Medical Center

Division of Cardiovascular Medicine

Cleveland, Ohio

Faculty Disclosures

These faculty report relationships with the following organizations:

Claudia Fine, MSW, MPH

Employment/stock ownership: Humana

Darrell W. Harrington, MD

Grants: Bristol-Myers Squibb, Pfizer

Honoraria: Janssen Pharmaceuticals, Inc

Alan K. Jacobson, MD, FACC

Consultant/paid advisory board: Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Janssen Pharmaceuticals, Inc, Pfizer

Honoraria/lecture fees: Boehringer Ingelheim, Bristol-Myers Squibb, Janssen Pharmaceuticals, Inc, Pfizer

Geno J. Merli, MD

Consultant/grants: Bristol-Myers Squibb, Johnson & Johnson, sanofi-aventis

Research support: Bristol-Myers Squibb, Johnson & Johnson, Portola Pharmaceuticals, sanofi-aventis

Edith Nutescu, PharmD, FCCP

Consultant/paid advisory board/grants: Janssen Pharmaceuticals, Inc

Tomas Villanueva, DO, MBA, FACPE, SFHM

Consultant/paid advisory board: American Regent, Janssen Pharmaceuticals, Inc, Novo Nordisk

Lecture fees: American Regent, AstraZeneca, Bristol-Myers Squibb, Creative Educational Concepts, Inc, Forest, Janssen Pharmaceuticals, Inc, Novo Nordisk, Pfizer

Albert L. Waldo, MD

Consultant: AtriCure, Biosense Webster, Biotronik, CardioInsight, ChanRx, Daiichi Sankyo, Gilead Sciences, Pfizer, sanofi-aventis, St. Jude Medical, Inc

Researcher: Gilead Sciences

Speaker: Bristol-Myers Squibb, Janssen Pharmaceuticals, Inc, Pfizer, sanofi-aventis

Gary M. Owens, MD; Kenneth L. Schaecher, MD, FACP, CPC; and Jacqueline Vance, RNC, BSN, CDONA/LTC, FACDONA, report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this supplement.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, the editorial staff, or any member of the editorial advisory board. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.

Download PDF: Participating Faculty: Improving Transitions of Care for Patients With Thromboembolic Disease